Don Lehr
Consigliere Generale presso PRECIGEN, INC.
Patrimonio netto: 753 376 $ in data 30/04/2024
Posizioni attive di Don Lehr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRECIGEN, INC. | Consigliere Generale | 01/01/2009 | - |
| Segretario Aziendale | - | - | |
Genten Therapeutics, Inc.
 Genten Therapeutics, Inc. BiotechnologyHealth Technology Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA. | Amministratore Delegato | - | - |
| Segretario Aziendale | - | - |
Storia della carriera di Don Lehr
Precedenti posizioni note di Don Lehr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GENVEC INC | Direttore/Membro del Consiglio | 16/06/2017 | - |
| Presidente | 16/06/2017 | - | |
| Treasurer | 16/06/2017 | - |
Formazione di Don Lehr
| Swarthmore College | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| The University of Maryland Francis King Carey School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
| General Counsel | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Genten Therapeutics, Inc.
Genten Therapeutics, Inc. BiotechnologyHealth Technology Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Don Lehr
- Esperienza